Ken Griffin's position in Nautilus Biotechnology is currently worth $75.1 Thousand. That's 0.00% of their equity portfolio (4201st largest holding). The first Nautilus Biotechnology trade was made in Q3 2021. Since then Ken Griffin bought shares eight more times and sold shares on five occasions. The investor's estimated purchase price is $267 Thousand, resulting in a loss of 72%.